← Back to work
Works cited by this work
130 works
Work: CTLA-4: a promising immunosuppressive immune checkpoint in prostate cancer therapy
Cancer Vaccines, Adjuvants, and Delivery Systems
Samantha Paston, Victoria A. Brentville, Peter Symonds +1
Review article20212 citationsABIEvolving Roles for Targeting CTLA-4 in Cancer Immunotherapy
Yinghao Zhao, Wei Yang, Yuanyuan Huang +3
Review article20182 citationsABICurrent understanding of CTLA-4: from mechanism to autoimmune diseases
Md. Munnaf Hossen, Yanmei Ma, Zhihua Yin +7
Review article20232 citationsABINivolumab versus Everolimus in Advanced Renal-Cell Carcinoma
Robert J. Motzer, Bernard Escudier, Ray McDermott +24
Article20152 citationsABINivolumab plus Ipilimumab in Advanced Non–Small-Cell Lung Cancer
Matthew D. Hellmann, Luis Paz‐Ares, Reyes Bernabe Caro +23
Article20192 citationsABI